DIABETIC RETINOPATHY

This study tested a supplement called Nuvastatic in 100 adults with type 2 diabetes and early-stage diabetic retinopathy (non-proliferative, without swelling in the center of the retina). The goal was to see if it could reduce retinal thickness and improve vision compared to a pl…

This study looked at whether taking omega-3 fatty acid supplements can help keep the small blood vessels in the eyes healthy for adults with type 1 diabetes. A total of 82 participants took daily omega-3 supplements and had regular eye exams to check for changes. The goal was to …

This study tested whether taking omega-3 supplements for 6 months could improve blood flow in the retina of people with mild to moderate diabetic retinopathy. 60 adults with diabetes and early eye damage were included. The main goal was to measure changes in tiny blood vessels in…

This study tested an eye injection called tarcocimab in 255 people with diabetic retinopathy, a complication of diabetes that can damage vision. The goal was to see if the drug could improve the condition better than a sham (fake) treatment. Participants received either the drug …

This early-phase study tested whether INV-102 eye drops can help control diabetic macular edema, a condition that causes vision loss in people with diabetes. Nineteen adults with non-proliferative diabetic retinopathy used the drops daily for 8 to 12 weeks. The goal was to see if…

This study tested a small, refillable implant placed in the eye that continuously releases the drug ranibizumab to control diabetic retinopathy. It involved 174 adults with moderate-to-severe non-proliferative diabetic retinopathy. The goal was to see if the implant could improve…

This study tested whether aflibercept, a medication injected into the eye, can improve areas of poor blood flow in the retina of people with diabetic retinopathy. The trial involved 38 adults with nonproliferative diabetic retinopathy and moderate retinal nonperfusion. The main g…

This study tested whether levodopa, a drug used for Parkinson's disease, can improve electrical signals in the retina of people with diabetes who have early signs of eye damage. 230 adults with diabetes took part to find the best dose and understand how the drug works. The goal i…

This study tested whether an artificial intelligence (AI) system can accurately detect diabetic eye disease and glaucoma from eye photos taken in primary care. About 900 adults with diabetes had their eye images read by both the AI and family doctors, with results compared to spe…

This study tested a new automated screening tool called OPTDR01 to detect diabetic retinopathy, a leading cause of vision loss. The tool is designed for use in primary care clinics to make screening more accessible, especially for underserved groups. Researchers enrolled 300 adul…

This study tested a nursing program designed to help patients relax during laser eye surgery for diabetes-related vision problems. 136 adults were split into two groups: one received standard care, and the other also got guided slow breathing, clear communication, and reassurance…

This study looked at whether monitoring moderate diabetic retinopathy (an eye condition caused by diabetes) through remote expert review of images is as effective as a traditional in-person eye exam. 97 adults with diabetes and moderate retinopathy took part. The goal was to see …

This study looked at 60 adults with type 2 diabetes and early-stage diabetic retinopathy. Researchers used special eye scans to measure blood flow in the retina and see if those measurements could predict which patients would develop more severe eye problems. The goal was to bett…

This study tested whether artificial intelligence (AI) can help doctors better predict how diabetic retinopathy (an eye disease caused by diabetes) will progress. Over 3,000 adults with diabetes had their eyes imaged and were followed for about 2 years. The goal was to create a s…

This study tested a program where a patient navigator helped 35 adults with diabetes who had not had an eye exam in the past year. The goal was to see if the program could help them get the eye exams they need to prevent blindness from diabetic retinopathy. The study focused on w…

This study looked at whether special eye scans can help predict which patients with diabetic macular edema (a common cause of vision loss in diabetes) will respond best to certain treatments. Researchers analyzed images from standard eye exams of 32 participants to find patterns …

This study tested different methods to find eye diseases like cataracts and glaucoma in communities to prevent blindness. Over 87,000 people aged 50 and older in Nepal took part. Communities were randomly assigned to one of four approaches: a full eye screening, cataract camps, c…

This study looked at whether certain substances in the blood (endocan, alarin, and galanin-like peptide) are linked to the severity of diabetic retinopathy, an eye problem caused by diabetes. Researchers measured these markers in 90 adults with and without diabetic eye damage and…

This study tested a new, low-cost eye-tracking system called CRYSTALSIGHT that uses artificial intelligence to monitor macular diseases like age-related macular degeneration and diabetic retinopathy. Twenty participants used the device at home to track eye movements, and research…